SCHEMBL8334516

SCHEMBL8334516

N=C(Nc1ccccc1)N(c1ccc(OCc2ccccc2)cc1)c1ccc(OCc2ccccc2)cc1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 4/20 0.58
KMT2A Q03164 4/20 0.58
CYP1A2 P05177 2/20 0.58
CYP2C19 P33261 2/20 0.58
NOX1 Q9Y5S8 2/20 0.56
NPC1 O15118 4/20 0.52
RAB9A P51151 4/20 0.52
SMN1; SMN2 Q16637 3/20 0.52
LTA4H P09960 2/20 0.52
ALDH1A1 P00352 4/20 0.51
RECQL P46063 1/20 0.50
LMNA P02545 1/20 0.50
PTGS1 P23219 1/20 0.50
SLC6A2 P23975 1/20 0.50
PTGS2 P35354 1/20 0.50
SLC6A3 Q01959 1/20 0.50
HIF1A Q16665 1/20 0.50
HDAC6 Q9UBN7 1/20 0.50
RXFP1 Q9HBX9 1/20 0.49
PTPN1 P18031 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4982442 0.99 MEN1 (0.57) MEN1KMT2ACYP1A2CYP2C19NOX1
SCHEMBL4987122 0.96 NOX1 (0.59) MEN1KMT2ACYP1A2CYP2C19NOX1
Oxalic Acid SCHEMBL4982635 0.94 NOX1 (0.57) MEN1KMT2ACYP1A2CYP2C19NOX1
SCHEMBL4982329 0.90 PDK1 (0.48) MEN1KMT2ACYP1A2CYP2C19NOX1
Hydrochloric Acid SCHEMBL4982388 0.89 PDK1 (0.47) MEN1KMT2ACYP1A2CYP2C19NOX1
SCHEMBL4983263 0.89 NOX1 (0.58) MEN1KMT2ACYP1A2CYP2C19NOX1
SCHEMBL4979740 0.83 NOX1 (0.64) MEN1KMT2ACYP1A2CYP2C19NOX1
SCHEMBL4981856 0.80 MEN1 (0.55) MEN1KMT2ACYP1A2CYP2C19NOX1
SCHEMBL8331017 0.79 LMNA (0.56) CYP1A2CYP2C19NOX1RAB9ASMN1; SMN2
SCHEMBL4979973 0.79 MEN1 (0.69) MEN1KMT2ACYP1A2CYP2C19NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1999002145-A1 COMBINATION DRUG THERAPIES COMPRISING AMINOGLYCOSIDE ANTIBIOTICS AND N,N'-DISUBSTITUTED GUANIDINES CAMBRIDGE NEUROSCIENCE, INC. (US) 1999-01-21 WO disclosed